Report: Sanofi will invest in Japanese firm to enter generics market

05/26/2010 | Reuters

Sanofi-Aventis will buy a stake of almost 5% in Japan's Nichi-Iko Pharmaceutical for about $55 million in a bid to enter the country's generic-drug market, according to a newspaper report. The companies also plan to create a joint venture and team up in developing bioengineered drugs, the report states.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC